Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Venous Thrombosis III: Interprofessional Care

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Session dedicated to macular degeneration related to age].

Bulletin de l'Academie nationale de medecine·2015

Same author

Displacement of retained subfoveal perfluorocarbon liquid after vitreoretinal surgery.

Archives of ophthalmology (Chicago, Ill. : 1960)·2008

Same author

CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration.

The Journal of clinical investigation·2007

Same author

[A blinding orphan disease: high myopia].

Bulletin de l'Academie nationale de medecine·2006

Same author

[Non-insulin-dependent diabetes: an expanding disease. Diabetic ophthalmopathy: diabetic retinopathy facts].

Bulletin de l'Academie nationale de medecine·2004

Same author

Late swelling and removal of Miragel buckles: a comparison with silicone indentations.

Retina (Philadelphia, Pa.)·2003

Search research articles

Related Experiment Video

Updated: Jul 7, 2026

Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats

Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats

Published on: March 7, 2025

[Anticoagulation and vitreoretinal surgery].

Dominique Chauvaud¹

¹Hôtel-Dieu, Service d'Ophtalmologie, 1 pl. du Parvis Notre-Dame, 75181 Paris Cédex 04.

Bulletin De L'Academie Nationale De Medecine

|January 30, 2008

Summary

Patients on anticoagulation therapy can safely undergo vitreoretinal surgery without altering their medication. This study found no increased complications, suggesting current anticoagulation management is appropriate for these procedures.

More Related Videos

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

Published on: April 14, 2026

Related Experiment Videos

Last Updated: Jul 7, 2026

Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats

Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats

Published on: March 7, 2025

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

Published on: April 14, 2026

Area of Science:

Ophthalmology
Cardiology
Vascular Surgery

Background:

Vitreoretinal surgery patients often require anticoagulation therapy.
Current guidelines for managing anticoagulation during vitreoretinal surgery are lacking.
Indications for anticoagulation include atrial fibrillation, coronary insufficiency, cerebrovascular disease, deep vein thrombosis, and prosthetic heart valves.

Purpose of the Study:

To evaluate the safety of continuing anticoagulation therapy in patients undergoing vitreoretinal surgery.
To determine if preoperative anticoagulation requires modification for vitreoretinal procedures.

Main Methods:

Sixty patients (mean age 73) on anticoagulation therapy underwent vitreoretinal surgery.
Patients received either vitamin K antagonists (22) or antiplatelet agents (38).
Surgery proceeded with standard sub-tenon anesthesia, without altering anticoagulation regimens.

Main Results:

Only one patient experienced an intraoperative complication (subretinal hemorrhage requiring retinectomy) during a major procedure for retinal detachment.
No other complications were reported in the study cohort.
The overall complication rate was low, suggesting safety.

Conclusions:

Ongoing anticoagulation therapy does not necessitate changes for patients undergoing vitreoretinal surgery.
Current anticoagulation management appears safe and effective for this patient population.
Further research may confirm these findings and inform guideline development.